Omega Healthcare Investors furnishes Item 2.02 results press release

Rhea-AI Filing Summary

Omega Healthcare Investors, Inc. (OHI) furnished a press release announcing its financial results for the quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 to a Form 8-K and is incorporated by reference.

The information was provided under Item 2.02 and, along with Exhibit 99.1, is furnished and not deemed “filed” under Section 18 of the Exchange Act. Additional exhibits include Exhibit 104 (Cover Page Interactive Data File).

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 10/30/2025 - 04:16 PM Learn about SEC filing dates

FAQ

What did OHI announce in this 8-K?

The company furnished a press release with financial results for the quarter ended September 30, 2025, attached as Exhibit 99.1.

Which reporting period does the press release cover for OHI?

It covers the quarter ended September 30, 2025.

Where can I find the detailed financial results for OHI?

See Exhibit 99.1, the press release incorporated by reference in the Form 8-K.

Is the information in the OHI 8-K considered filed or furnished?

It is furnished under Item 2.02 and is not deemed “filed” under Section 18 of the Exchange Act.

What exhibits are included with OHI’s 8-K?

The filing includes Exhibit 99.1 (press release) and Exhibit 104 (Cover Page Interactive Data File).

What is OHI’s trading symbol and exchange?

The trading symbol is OHI on the New York Stock Exchange.

0000888491false00008884912025-10-302025-10-30

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_______________

​

FORM 8-K

_______________

​

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

​

Date of Report (Date of earliest event reported): October 30, 2025

​

OMEGA HEALTHCARE INVESTORS, INC.

(Exact name of registrant as specified in its charter)

​

Maryland	1-11316	38-3041398
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

​

303 International Circle,

Suite 200

Hunt Valley, Maryland 21030

(Address of principal executive offices / Zip Code)

​

(410) 427-1700

(Registrant’s telephone number, including area code)

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐     Written communications pursuant to Rule 425 under the Securities Act.

☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act.

☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

​

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.10 par value	OHI	New York Stock Exchange

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

​

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

​

Item 2.02     Regulation FD Disclosure

​

On October 30, 2025, Omega Healthcare Investors, Inc. (“Omega”) issued a press release regarding its financial results for the quarter ended September 30, 2025. Omega’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

​

The information in this Item 2.02 of this Current Report on Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

​

Item 9.01     Financial Statements and Exhibits

​

(d) Exhibits

​

Exhibit No. Description of Exhibit

​

99.1Press release issued by the Company on October 30, 2025

104Cover Page Interactive Data File (embedded within the Inline XBRL document)

​

​

SIGNATURES

​

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

​

​	OMEGA HEALTHCARE INVESTORS, INC.
​	​
​	​	​
Dated: October 30, 2025	By:	/s/ Gail D. Makode
​	​	Gail D. Makode
​	​	Chief Legal Officer, General Counsel

​

​

​

​

​

​

​

​

​

​

​